However, it is worth noting that randomized controlled trials of cholinesterase inhibitors for the treatment of dementia due to Alzheimer’s disease (AD) have enrolled participants significantly younger than the mean age of actual patients with AD [70]. The gene discussed is BCHE; the disease is dementia.